Harry Heller is a scholar working on Molecular Biology, Nephrology and Surgery.
According to data from OpenAlex, Harry Heller has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Surgery. Recurrent topics in Harry Heller's work include Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Inflammasome and immune disorders (7 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). Harry Heller is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Inflammasome and immune disorders (7 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). Harry Heller collaborates with scholars based in Israel, Germany and India. Harry Heller's co-authors include J Gafni, E Sohar, Jane Heller, M Pras, P. Hilgard, C. G. Schmidt, Shlomo Shibolet, Mordechai Pras, Irving Karten and George E. Ehrlich and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.
In The Last Decade
Harry Heller
25 papers
receiving
1.5k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Familial Mediterranean fever
1967829 citationsE Sohar, J Gafni et al.The American Journal of Medicineprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
This map shows the geographic impact of Harry Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Heller more than expected).
This network shows the impact of papers produced by Harry Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Heller. The network helps show where Harry Heller may publish in the future.
Co-authorship network of co-authors of Harry Heller
This figure shows the co-authorship network connecting the top 25 collaborators of Harry Heller.
A scholar is included among the top collaborators of Harry Heller based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Harry Heller. Harry Heller is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Laffitte, Emmanuel, et al.. (2003). [Intermittent cutaneous tumefaction after a trip to Vietnam].. PubMed. 130(4). 463–4.3 indexed citations
2.
Heller, Harry, et al.. (1973). Degradation of 14 C-labeled group A streptococci and micrococci in muscular lesions in the mouse.. PubMed. 9(4). 483–6.5 indexed citations
3.
Gafni, J, et al.. (1968). Isolation of highly purified amyloid.. PubMed. 3(4). 569–71.3 indexed citations
4.
Gafni, J, et al.. (1968). Chemical aspects of amyloid-Congo red binding.. PubMed. 3(4). 572–4.3 indexed citations
5.
Shibolet, Shlomo, H. J. Merker, E Sohar, J Gafni, & Harry Heller. (1967). Cellular proliferation during the development of amyloid. Electron microscopic observations on the kidneys of Leishmania-infected hamsters.. PubMed. 48(2). 244–9.12 indexed citations
Pras, M, et al.. (1961). [Immunological studies by the agar gel diffusion technic in familial Mediterranean fever (FMF). Preliminary report].. PubMed. 60. 84–6.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.